Repare Therapeutics Inc Stock Ownership - Who owns Repare Therapeutics?

Insider buying vs selling

Have Repare Therapeutics Inc insiders been buying or selling?
Steve ForteEVP CHIEF FINANCIAL OFFICER2024-04-01789$4.61
Lloyd Mitchell SegalPRESIDENT AND CEO2024-04-012,491$4.63
Maria KoehlerEVP CHIEF MEDICAL OFFICER2024-04-01300$4.66
Michael ZindaEVP CHIEF SCIENTIFIC OFFICER2024-04-01410$4.66
Maria KoehlerEVP CHIEF MEDICAL OFFICER2024-03-28500$4.64
Michael ZindaEVP CHIEF SCIENTIFIC OFFICER2024-03-28450$4.64
Lloyd Mitchell SegalPRESIDENT AND CEO2024-03-282,650$4.62
Steve ForteEVP CHIEF FINANCIAL OFFICER2024-03-28825$4.62
Maria KoehlerEVP CHIEF MEDICAL OFFICER2024-03-27500$4.62
Steve ForteEVP CHIEF FINANCIAL OFFICER2024-03-27825$4.62

1 of 4

RPTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPTX insiders and whales buy or sell their stock.

RPTX Shareholders

What type of owners hold Repare Therapeutics Inc stock?
Bvf Inc24.35%10,333,600$36.37MInstitution
Ansbert Gadicke9.15%3,882,485$13.67MInsider
Davis Jerel8.66%3,675,793$12.94MInsider
Versant Ventures V LLC8.60%3,650,662$12.85MInsider
Versant Vantage I LP8.60%3,650,662$12.85MInsider
Orbimed Advisors LLC7.83%3,322,488$11.70MInstitution
Blue Owl Capital Holdings LP7.36%3,122,499$10.99MInstitution
Mpm Bioventures 2014 LP7.08%3,003,772$10.57MInsider
Ark Investment Management LLC6.37%2,703,783$9.52MInstitution
Deep Track Capital LP6.32%2,684,344$9.45MInstitution

1 of 3

RPTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPTX60.47%39.53%Net BuyingNet Selling
TELO0.27%16.90%Net Buying
GALT8.77%91.23%Net BuyingNet Selling
ZURA26.68%73.32%Net SellingNet Buying
ELEV78.86%21.14%Net SellingNet Selling

Repare Therapeutics Stock Ownership FAQ

Who owns Repare Therapeutics?

Repare Therapeutics (NASDAQ: RPTX) is owned by 83.66% institutional shareholders, 54.69% Repare Therapeutics insiders, and 0.00% retail investors. Ansbert Gadicke is the largest individual Repare Therapeutics shareholder, owning 3.88M shares representing 9.15% of the company. Ansbert Gadicke's Repare Therapeutics shares are currently valued at $13.67M.

If you're new to stock investing, here's how to buy Repare Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.